Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by skys1on Jan 27, 2019 2:32pm

127 Views

Post# 29286768

RE:RE:RE:RE:RE:RE:RE:Warrents defending investments / solid data points.

At this point everything is on the table except the TLT process for NMIBC for No. America. However the licensing only for that process for the rest of the world is also on the table. Why are they keeping NMIBC for No. America for themselves? Who knows, but maybe they want to insure a cushy well paying job for themselves? That's a possibility. However a hostile bid by a member of big pharma could kill all that scenario if the hostile bidder could entice a majority of shareholders to accept their proffered share price.

Bullboard Posts

High-growth stock Happy Belly opens first Rosie's Burgers in Alberta